PER
Click for more information
0.00% 6.7¢ percheron therapeutics limited

Ann: Positive results reaffirm plans to advance ATL1102 to P2b, page-87

  1. itsagas
    13,150 Posts.
    lightbulb Created with Sketch. 1380
    clock Created with Sketch.
    19/12/19
    04:50
    Post #: 42041418
    https://themarketherald.com.au/antisense-therapeutics-asxanp-receives-positive-data-from-phase-ii-atl1102-dmd-trial-2019-12/
    ANP Price at posting: 8.6¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 8  Upvote
    lightbulb Created with Sketch. 1  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

STX Strike reports flow test success at 100% owned Walyering-7
right-arrow Created with Sketch.
NEWS A Super PITch is key in the competition for capital
right-arrow Created with Sketch.
NXG Cost blow-out for Rook I uranium project sees share plummet for NexGen
right-arrow Created with Sketch.
VMS Venture to sniff out high-grade REE targets at Jupiter project, WA
right-arrow Created with Sketch.
GRX GreenX picks up prospective copper project in Germany
right-arrow Created with Sketch.
DVP Commodity house Trafigura funds Develop Global's copper-zinc Woodlawn play with offtake deal in place
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
6.7¢ 		Change
0.000(0.00%) 		Mkt cap ! $57.69M
Open High Low Value Volume
6.5¢ 6.7¢ 6.3¢ $32.42K 496.7K

Buyers (Bids)

No. Vol. Price($)
1 18746 6.5¢
 

Sellers (Offers)

Price($) Vol. No.
6.9¢ 150000 1
View Market Depth
Last trade - 11.55am 06/08/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.